Reports Archive   Year   
Date Title Pages Source Download
Nov-22 Specialty Chemicals   24 Motilal Oswal
Nov-22 Sharp decline in volume for Oct-22   8 Emkay Research
Oct-22 Margins remain under pressure; revenue growth to recover   5 Nirmal Bang
Oct-22 Jul-Sep'22 Earnings Preview   13 Prabhudas Lilladher
Sep-22 Brand matters   142 Nirmal Bang
Sep-22 NLEM 2022   4 ICICI Securities
Sep-22 IPM growth in low single digits for the first five months of FY23   8 Emkay Research
Sep-22 Third consecutive month of healthy growth steered by price hikes   24 Anand Rathi
Sep-22 USFDA regulatory risk remains unabated   12 Motilal Oswal
Sep-22 Key prescription trends in the US market   21 Nirmal Bang
Aug-22 Continued input cost wedged earnings   6 Centrum Research
Jul-22 Pharma Players' FY23 Profitability Margins May See 200-250 bps Dip   4 CARE Edge
Jul-22 Apr-Jun'22 Earnings Preview   12 Prabhudas Lilladher
Jul-22 Q1FY23 Preview: Margin pressure softens earnings   6 Phillip Capital
Jun-22 High base effect to limit growth in 1QFY23   4 Nirmal Bang
Jun-22 Medplus Health Services - A dose of healthy growth   55 Edelweiss Securities
Jun-22 Indian Healthcare Industry to Surpass USD 130 billion by FY24   5 CARE Edge
May-22 Subdued growth on a Covid'19-boosted high base   22 Anand Rathi
May-22 Sharp off-take of COVID drugs in the past year drags IPM in Apr' 22   26 Motilal Oswal
Apr-22 Chronic Heart Failure opportunity in India – Large head room for growth   3 Nirmal Bang
Apr-22 Q4 FY22 Healthcare Results Preview   12 Anand Rathi
Apr-22 Sequentially flattish quarter expected   4 Nirmal Bang
Mar-22 IPM: Seasonal weakness and a return to trend-line growth   13 Emkay Research
Mar-22 Subdued IPM growth, dragged down by sluggish volumes   23 Anand Rathi
Feb-22 Domestic driven   11 Centrum Research
Jan-22 Oct-Dec'21 Earnings Preview   12 Prabhudas Lilladher
Jan-22 Margins to remain under pressure; Domestic market growth to slow down   4 Nirmal Bang